The Structural Biology Core will be a shared central resource to enable researchers at the University of Pennsylvania to bring molecular and structural analysis and understanding to their research projects on AIDS- related macromolecules. Molecular mechanism, molecular structure and drug design all are subjects of currently funded research at the University. They also are common themes in several upcoming projects. A common need in these projects as well as those on the biology of AIDS-related macromolecules is to enable the use of structural biology approaches in order to learn more about structure and mechanism and to use that information for structure- and mechanism-based antagonist design. The goal of the Structural Biology Core will be to provide services which facilitate the use of structural biology to solve AIDS-related research problems. The four main functions of the Structural Biology Core will be: (1) Protein Production, including scaled up expression and purification to provide materials for structural and mechanistic studies; (2) Interaction Analysis, focusing on optical biosensor analysis of macromolecular interaction kinetics and characterization of assembly mechanisms in HIV-1 and the pathogenesis of AIDS; (3) Structure-Function Analysis, including molecular graphics visualization of high resolution structures and structural guidance for mutagenic analysis; and (4) Resource Networking, in particular guiding users to technology resources beyond the Core for specialized biophysical, computational and high resolution structure determination. A key strength of the CFAR at the University of Pennsylvania will be to bring together researchers investigating the biology and chemistry of immunodeficiency viruses and AIDS with the resources to elucidate molecular and structural properties and to use these properties as lead information in drug design. Coordinated research and collaborations will be encouraged amongst biologists, chemists and structural biologists. The Structure Biology Core will provide a centralized resource which will provide protein materials, initiate interaction analyses and structure-function studies, facilitate and lead AIDS-related projects into the structural biology area and hence help meet the molecular, structural and drug design goals of AIDS research at UPenn.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-02
Application #
6327583
Study Section
Project Start
2000-07-15
Project End
2001-06-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
$165,421
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79
Gowda, Charitha; Lott, Stephen; Grigorian, Matthew et al. (2018) Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study. Open Forum Infect Dis 5:ofy076
Clarke, Erik L; Connell, A Jesse; Six, Emmanuelle et al. (2018) T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. Genome Med 10:70
Coviello, D M; Lovato, R; Apostol, K et al. (2018) Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders. Community Ment Health J :
Martei, Yehoda M; Pace, Lydia E; Brock, Jane E et al. (2018) Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge. Clin Lab Med 38:161-173
Ojikutu, Bisola O; Bogart, Laura M; Higgins-Biddle, Molly et al. (2018) Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav 22:3576-3587
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Wood, Sarah; Ratcliffe, Sarah; Gowda, Charitha et al. (2018) Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV. AIDS 32:895-902
Shin, S S; Modongo, C; Zetola, N M et al. (2018) High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana. Int J Tuberc Lung Dis 22:366-370
Genn, Leah; Chapman, Jennifer; Okatch, Harriet et al. (2018) Pharmacy Refill Data are Poor Predictors of Virologic Treatment Outcomes in Adolescents with HIV in Botswana. AIDS Behav :

Showing the most recent 10 out of 775 publications